Elypta
Elypta is a Stockholm-based biotechnology company focused on preventing cancer mortality through a liquid biopsy platform for detection and monitoring of the disease.
5
Funding Rounds
$56.7m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Je** Ni***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Elypta has raised a total of $55.4m in funding over 5 rounds.
Key Insights:
- Elypta Series A round, June 2022: $21m
- Elypta June 2022 Series A Funding Round: $21m
- Elypta , January 2020: $6.7m
- Elypta January 2020 Seed Funding Round: $6.7m
Elypta Series A round, June 2022
$21m
Elypta June 2022 Series A Funding Round
$21m
Elypta , January 2020
$6.7m
Elypta January 2020 Seed Funding Round
$6.7m
Industries
Elypta is active in the following industries:
- Medical diagnostics
- Biomedical engineering
- Cancer
- Diagnosis
- Oncology
- Diagnostic Equipment
- Healthcare
- Engineering
- Technology
- Biology
- Biotechnology
- Internal medicine
- Medicine
- Health technology
- Deep Tech